Safety, Pharmacokinetics, and Acceptability of a Tenofovir Rectal Microbicide Douche Among Young Men Who Have Sex With Men: The DREAM ATN Study (ATN 163)
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf349 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Jose A Bauermeister und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, Tenofovir. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Background
Young men who have sex with men (YMSM) are disproportionately affected by human immunodeficiency virus (HIV); however, use of oral preexposure prophylaxis (PrEP) remains suboptimal. This study evaluated the safety, pharmacokinetics (PK), pharmacodynamics (PD), and acceptability of a novel tenofovir (TFV) rectal microbicide douche for HIV prevention.
Methods
Eight HIV-negative YMSM (aged 18–24 years) participated in a single-dose, open-label trial. Each received 660 mg of TFV in a 125-mL rectal douche. Safety was assessed via clinical monitoring and adverse event (AE) reporting. PK analysis measured TFV and TFV-diphosphate (TFV-DP) concentrations in blood and rectal tissue. PD was evaluated using ex vivo HIV-1 challenge assays in rectal biopsies.
Results
No serious AEs occurred. Five mild to moderate AEs (eg, nausea, hyperglycemia) were reported, none related to the product. Median peak plasma TFV concentration (14.5 ng/mL) remained below levels seen with oral TDF. Median peak (24-hour) rectal tissue cell TFV-DP concentrations were 8319 fmol/106 cells with a corresponding 0.9 log10 HIV-1 p24 antigen reduction observed in ex vivo challenge assays. Rectal tissue TFV-DP concentrations exceeded those associated with on-demand oral 2-1-1 dosing from 1 to 72 hours and suppressed HIV-1 p24 antigen production in colonic explants. Acceptability was high: 87.5% reported satisfaction, and 75% would consider future use.
Conclusions
The TFV rectal douche was safe, well tolerated, and acceptable to YMSM. Its favorable PK and PD profiles support further investigation as a behaviorally congruent, on-demand PrEP strategy. Additional studies are needed to assess long-term safety and efficacy in larger, more diverse populations. Clinical Trials Registration NCT04686279.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Craig-Dalsimer Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- School of Nursing, Florida State University, Tallahassee, Florida, USA.
ORCID-Profile: Jose A Bauermeister, Sandra Massih, Mark A Marzinke, Ruohui Zheng, Rahul P Bakshi, Willey Lin, Lisa Hightow-Weidman, Craig W Hendrix
Förderung
- NIAID NIH HHS
- NICHD NIH HHS
Zitieren
APA
Bauermeister, J. A., Arrington-Sanders, R., Coleman-Lewis, J., Bertagnolli, L. N., Massih, S., Marzinke, M. A., Fuchs, E. J., Zheng, R., Anderson, T., Addison, B., Yang, Y. H., Breakey, J., Hoffman, J., Bakshi, R. P., Zak, A. M., Beselman, S., Lin, W., Agwu, A. L., Hightow-Weidman, L., & Hendrix, C. W. (2025). Safety, Pharmacokinetics, and Acceptability of a Tenofovir Rectal Microbicide Douche Among Young Men Who Have Sex With Men: The DREAM ATN Study (ATN 163). The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf349
Vancouver
Bauermeister JA, Arrington-Sanders R, Coleman-Lewis J, Bertagnolli LN, Massih S, Marzinke MA, et al. Safety, Pharmacokinetics, and Acceptability of a Tenofovir Rectal Microbicide Douche Among Young Men Who Have Sex With Men: The DREAM ATN Study (ATN 163). The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf349
BibTeX
@article{Bauermeister2025,
author = {Bauermeister, Jose A and Arrington-Sanders, Renata and Coleman-Lewis, Jessica and Bertagnolli, Lynn N and Massih, Sandra and Marzinke, Mark A and Fuchs, Edward J and Zheng, Ruohui and Anderson, Thuy and Addison, Bonnie and Yang, Yeng H and Breakey, Jennifer and Hoffman, Jennifer and Bakshi, Rahul P and Zak, Alexander M and Beselman, Sasha and Lin, Willey and Agwu, Allison L and Hightow-Weidman, Lisa and Hendrix, Craig W},
title = {Safety, Pharmacokinetics, and Acceptability of a Tenofovir Rectal Microbicide Douche Among Young Men Who Have Sex With Men: The DREAM ATN Study (ATN 163)},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf349}
}
EUVIMED